Aurinia Pharmaceuticals Inc (AUPH)

Cost of Revenue

$30.04M

TTM · Period ending: · USD

AUPH logo

AUPH Cost of Revenue

Latest reported$30.04M
AUPH TTM Cost of Revenue ($678.44K → $30.04M)
High-resolution chart · PNG

AUPH cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aurinia Pharmaceuticals Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
770,886
688,676
547,969
551,124
620,024
678,443
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.